Category: Pharmaceuticals
Global Pharmaceuticals
-
Global Radiation Oncology Databank Market Report
... 2031. Internal Beam Radiation Therapy segment is expected to be the highest contributor to this market, with $5,909.9 Million in 2022, and is anticipated to reach $13,883.2 Million by 2031, registering a CAGR of 10.01%. ... Read More
-
Global Oncology NGS Databank Market Report
... 2031. Targeted Sequencing & Resequencing segment is expected to be the highest contributor to this market, with $242.5 Million in 2022, and is anticipated to reach $709.3 Million by 2031, registering a CAGR of 12.73%. ... Read More
-
Global Acute Myeloid Leukemia Therapeutics Databank Market Report
... 5.19% from 2023 to 2031. Targeted Therapy and Immunotherapy segment is expected to be the highest contributor to this market, with $5,909.9 Million in 2022, and is anticipated to reach $8,938.5 Million by 2031, registering ... Read More
-
Global Anti-Counterfeit Databank Market Report
... & Trace segment is expected to be the highest contributor to this market, with $71,792.0 Million in 2022, and is anticipated to reach $172,567.2 Million by 2031, registering a CAGR of 10.30%. Covert segment is ... Read More
-
Global Antiplatelet Databank Market Report.pdf
... to 2031. Sclerotherapy segment is expected to be the highest contributor to this market, with $1,010.7 Million in 2022, and is anticipated to reach $1,616.5 Million by 2031, registering a CAGR of 5.40%. Surgical Ligation ... Read More
-
Global Antiplatelet Databank Market Report
... providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market ... Read More
-
Global Aortic Aneurysm Databank Market Report
... 2029. Ambulatory Surgery Centers segment is expected to be the highest contributor to this market, with $2,708.4 Million in 2020, and is anticipated to reach $3,655.4 Million by 2029, registering a CAGR of 3.43%. Hospitals ... Read More
-
Global Cellulite Treatment Databank Market Report
... 2029. Non-invasive segment is expected to be the highest contributor to this market, with $453.4 Million in 2020, and is anticipated to reach $1,008.1 Million by 2029, registering a CAGR of 9.34%. Minimally Invasive segment ... Read More
-
Global Legal Marijuana Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... The commercial marijuana industry exists on a state-by-state basis, and all medical and recreational programs are technically in violation of federal drug laws. The U.S. Department of Justice issued some guidelines in recent years that ... Read More
-
Global Drugs for Malaria Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The ... Read More
-
Global Legal Marijuana Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... exists on a state-by-state basis, and all medical and recreational programs are technically in violation of federal drug laws. The U.S. Department of Justice issued some guidelines in recent years that helped the marijuana industry ... Read More
-
Global Breast Ultrasound Databank Market Report
... 2031. Automated Breast Ultrasound (ABUS) segment is expected to be the highest contributor to this market, with $1,520.8 Million in 2022, and is anticipated to reach $3,904.5 Million by 2031, registering a CAGR of 11.11%. ... Read More
-
Global Digital Diabetes Management Databank Market Report
... 2023 to 2031. Continuous Blood Glucose Monitoring System segment is expected to be the highest contributor to this market, with $4,876.9 Million in 2022, and is anticipated to reach $9,140.7 Million by 2031, registering a ... Read More
-
Global Mouth Ulcers Treatment Databank Market Report
... report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of ... Read More
-
Global Castrate-resistant Prostate Cancer Databank Market Report
... 2023 to 2031. Hormonal Therapy segment is expected to be the highest contributor to this market, with $7,227.4 Million in 2022, and is anticipated to reach $12,564.7 Million by 2031, registering a CAGR of 6.39%. ... Read More
-
Global Congestive Heart Failure Treatment Devices Databank Market Report
... CAGR of 6.88% from 2023 to 2031. Implantable Cardioverter Defibrillators segment is expected to be the highest contributor to this market, with $9,692.6 Million in 2022, and is anticipated to reach $16,736.9 Million by 2031, ... Read More
-
Global Excipients Databank Market Report
... providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market ... Read More
-
Global E-Prescribing Databank Market Report
... segment is expected to be the highest contributor to this market, with $1,822.5 Million in 2022, and is anticipated to reach $11,675.6 Million by 2031, registering a CAGR of 23.06%. Services segment is anticipated to ... Read More
-
Global Artificial Pancreas Device System Databank Market Report.pdf
... 5.40% from 2023 to 2031. Sclerotherapy segment is expected to be the highest contributor to this market, with $1,010.7 Million in 2022, and is anticipated to reach $1,616.5 Million by 2031, registering a CAGR of ... Read More
-
Global Ethanolamines Databank Market Report
... (MEA) segment is expected to be the highest contributor to this market, with $657.7 Million in 2022, and is anticipated to reach $974.3 Million by 2031, registering a CAGR of 4.50%. Monoethanolamine (MEA) and Triethanolamine ... Read More
-
Global Neurology Devices Databank Market Report
... 2031. Neurostimulation segment is expected to be the highest contributor to this market, with $4,206.2 Million in 2022, and is anticipated to reach $7,326.0 Million by 2031, registering a CAGR of 6.41%. CSF Management segment ... Read More
-
Global Insomnia Therapeutics Databank Market Report
... 2031. Drugs segment is expected to be the highest contributor to this market, with $3,103.4 Million in 2022, and is anticipated to reach $4,664.6 Million by 2031, registering a CAGR of 4.67%. Medical Devices segment ... Read More
-
Global Multiple Sclerosis Therapeutics Databank Market Report
... 2021 to 2029. Small-molecule Drugs segment is expected to be the highest contributor to this market, with $6,472.6 Million in 2020, and is anticipated to reach $12,240.1 Million by 2029, registering a CAGR of 7.38%. ... Read More
-
Global Wound Care Biologics Databank Market Report
... 2023 to 2031. Ulcers segment is expected to be the highest contributor to this market, with $730.2 Million in 2022, and is anticipated to reach $1,212.3 Million by 2031, registering a CAGR of 5.84%. Surgical ... Read More
-
Global Cell And Gene Therapy Clinical Trials Databank Market Report
... at a CAGR of 6.20% from 2021 to 2029. Cardiology segment is expected to be the highest contributor to this market, with $9,361.8 Million in 2020, and is anticipated to reach $16,753.6 Million by 2029, ... Read More